A review of mometasone furoate/formoterol in the treatment of asthma

Bibliography

• Available from: http://www.ginasthma.org/uploads/users/files/GINA_Report2011_May4.pdf
   Google Scholar
• Bousquet J, Bousquet PJ, Godard P, Daures JP. The public health implications of asthma. Bull World Health Organ 2005;83(7):548-54
   PubMed Web of Science ®Google Scholar
• Rabe KF, Adachi M, Lai CK, Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. J Allergy Clin Immunol 2004;114(1):40-7
   PubMed Web of Science ®Google Scholar
• Woodruff PG, Modrek B, Choy DF, T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am J Respir Crit Care Med 2009;180(5):388-95
   PubMed Web of Science ®Google Scholar
• http://www.ginasthma.org/pdf/GINA_Report_2010.pdf
   Google Scholar
• Frois C, Wu EQ, Ray S, Colice GL. Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol. Clin Ther 2009;31(12):2779-803
   PubMed Web of Science ®Google Scholar
• Hirst C, Calingaert B, Stanford R, Castellsague J. Use of long-acting beta-agonists and inhaled steroids in asthma: meta-analysis of observational studies. J Asthma 2010;47(4):439-46
   PubMed Web of Science ®Google Scholar
• Laforest L, El Hasnaoui A, Pribil C, Asthma patients' self-reported behaviours toward inhaled corticosteroids. Respir Med 2009;103(9):1366-75
   PubMed Web of Science ®Google Scholar
• Drugs@FDA. Available from: http://www.accessdata.fda.gov/scripts/cder/drugsatfda/
   Google Scholar
• Busse WW, Bleecker ER, Bateman ED, Fluticasone furoate demonstrates efficacy in patients with asthma symptomatic on medium doses of inhaled corticosteroid therapy: an 8-week, randomised, placebo-controlled trial. Thorax 2012;67(1):35-41
   PubMed Web of Science ®Google Scholar
• Bateman ED, Bleecker ER, Lotvall J, Dose effect of once-daily fluticasone furoate in persistent asthma: a randomized trial. Respir Med 2012;106(5):642-50
   PubMed Web of Science ®Google Scholar
• Woodcock A, Bleecker ER, Busse WW, Fluticasone furoate: once-daily evening treatment versus twice-daily treatment in moderate asthma. Respir Res 2011;12:160
   PubMed Web of Science ®Google Scholar
• Kelly HW, Nelson HS. Potential adverse effects of the inhaled corticosteroids. J Allergy Clin Immunol 2003;112(3):469-78; quiz 479
   PubMed Web of Science ®Google Scholar
• Fardon TC, Lee DK, Haggart K, Adrenal suppression with dry powder formulations of fluticasone propionate and mometasone furoate. Am J Respir Crit Care Med 2004;170(9):960-6
   PubMed Web of Science ®Google Scholar
• Frampton JE. Mometasone/formoterol inhalation aerosol: in asthma uncontrolled on medium- or high-dose inhaled corticosteroids. Drugs 2012;72(9):1229-41
   PubMed Web of Science ®Google Scholar
• Bousquet J. Mometasone furoate: an effective anti-inflammatory with a well-defined safety and tolerability profile in the treatment of asthma. Int J Clin Pract 2009;63(5):806-19
   PubMed Web of Science ®Google Scholar
• McCormack PL, Plosker GL. Inhaled mometasone furoate: A review of its use in persistent asthma in adults and adolescents. Drugs 2006;66(8):1151-68
   PubMed Web of Science ®Google Scholar
• Linden A, Rabe KF, Lofdahl CG. Pharmacological basis for duration of effect: formoterol and salmeterol versus short-acting beta 2-adrenoceptor agonists. Lung 1996;174(1):1-22
   PubMed Web of Science ®Google Scholar
• Op't Holt TB. Inhaled beta agonists. Respir Care 2007;52(7):820-32
   Google Scholar
• Barnes PJ. Effect of beta-agonists on inflammatory cells. J Allergy Clin Immunol 1999;104(2 Pt 2):S10-17
   Google Scholar
• Bartow RA, Brogden RN. Formoterol. An update of its pharmacological properties and therapeutic efficacy in the management of asthma. Drugs 1998;55(2):303-22
   Google Scholar
• Derom EY, Pauwels RA. Time course of bronchodilating effect of inhaled formoterol, a potent and long acting sympathomimetic. Thorax 1992;47(1):30-3
   PubMed Web of Science ®Google Scholar
• Lecaillon JB, Kaiser G, Palmisano M, Pharmacokinetics and tolerability of formoterol in healthy volunteers after a single high dose of Foradil dry powder inhalation via Aerolizer. Eur J Clin Pharmacol 1999;55(2):131-8
   PubMed Web of Science ®Google Scholar
• Ito K, Chung KF, Adcock IM. Update on glucocorticoid action and resistance. J Allergy Clin Immunol 2006;117(3):522-43
   PubMed Web of Science ®Google Scholar
• Barnes PJ. How corticosteroids control inflammation: Quintiles Prize Lecture 2005. Br J Pharmacol 2006;148(3):245-54
   PubMed Web of Science ®Google Scholar
• Adcock IM, Ito K, Barnes PJ. Histone deacetylation: an important mechanism in inflammatory lung diseases. COPD 2005;2(4):445-55
   PubMedGoogle Scholar
• Barnes PJ, Adcock IM. How do corticosteroids work in asthma? Ann Intern Med 2003;139(5 Pt 1):359-70
   PubMed Web of Science ®Google Scholar
• Valotis A, Neukam K, Elert O, Hogger P. Human receptor kinetics, tissue binding affinity, and stability of mometasone furoate. J Pharm Sci 2004;93(5):1337-50
   PubMed Web of Science ®Google Scholar
• Derendorf H, Nave R, Drollmann A, Relevance of pharmacokinetics and pharmacodynamics of inhaled corticosteroids to asthma. Eur Respir J 2006;28(5):1042-50
   PubMed Web of Science ®Google Scholar
• Nathan RA, Nolte H, Pearlman DS; P04334 Study Investigators. Twenty-six-week efficacy and safety study of mometasone furoate/formoterol 200/10 microg combination treatment in patients with persistent asthma previously receiving medium-dose inhaled corticosteroids. Allergy Asthma Proc 2010;31(4):269-79
   Google Scholar
• Weinstein SF, Corren J, Murphy K, Twelve-week efficacy and safety study of mometasone furoate/formoterol 200/10 microg and 400/10 microg combination treatments in patients with persistent asthma previously receiving high-dose inhaled corticosteroids. Allergy Asthma Proc 2010;31(4):280-9
   Google Scholar
• Meltzer EO, Kuna P, Nolte H, Mometasone furoate/formoterol reduces asthma deteriorations and improves lung function. Eur Respir J 2012;39(2):279-89
   Google Scholar
• Wyrwich KW, Ireland AM, Navaratnam P, An assessment of change in asthma control among adolescents and adults with persistent asthmain mometasone furoate/formoterol fumarate clinical trials. J Asthma 2011;48(1):48-56
   PubMed Web of Science ®Google Scholar
• Maspero JF, Nolte H, Cherrez-Ojeda I. P04139 Study Group. Long-term safety of mometasone furoate/formoterol combination for treatment of patients with persistent asthma. J Asthma 2010;47(10):1106-15
   PubMed Web of Science ®Google Scholar
• Bernstein DI, Hebert J, Cheema A, Efficacy and onset of action of mometasone furoate/formoterol and fluticasone propionate/salmeterol combination treatment in subjects with persistent asthma. Allergy Asthma Clin Immunol 2011;7:21
   PubMed Web of Science ®Google Scholar